DiaSorin

DiaSorin is a prominent player in the medical devices and manufacturing sector, established in 2006. The company specializes in high-throughput antigen tests and advanced molecular diagnostic solutions. Their core product portfolio includes the LIAISON testing platform and Simplexa diagnostic kits, which are essential for clinical laboratories and healthcare facilities. These technologies facilitate precise screening and monitoring for various diseases, supporting clinical decision-making through automated testing and sensitive immunoassay capabilities.

Operating with a workforce of 1,000-5,000 employees, DiaSorin maintains a strategic operational footprint across 2 locations. The company serves the B2B healthcare market, delivering specialized diagnostic tools that address complex clinical needs. Their global reach spans North America, Europe, Asia, and South America, ensuring that healthcare providers have access to reliable diagnostic infrastructure. By focusing on high-quality manufacturing and innovative R&D, the firm maintains a competitive edge in the global medical diagnostics landscape.

DiaSorin’s commitment to excellence is reflected in its rigorous regulatory compliance, including FDA Emergency Use Authorization and CE marking for its diagnostic products. The organization continues to expand its menu of tests to cover diverse medical fields, from bone health to infectious disease monitoring. Meet DiaSorin's team to learn about the leadership driving these technological advancements. Through continuous investment in molecular diagnostic innovation, the company remains a critical partner for healthcare systems worldwide, providing the tools necessary for accurate patient assessment and effective disease management.